ELOX SCHEDULE 13G: SEC filing

Samsara BioCapital, L.P. and affiliated entities

Filed with the SEC on · accession 0001699737-26-000018

ELOX filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. Samsara BioCapital, L.P. and affiliated entities filed a joint Schedule 13G reporting their beneficial ownership of Eloxx Pharmaceuticals common stock. The stock moved -1.6% by the first close after the filing.

Summary of the filing

Samsara BioCapital, L.P. and affiliated entities filed a joint Schedule 13G reporting their beneficial ownership of Eloxx Pharmaceuticals common stock. The filing is a passive ownership disclosure with no stated intent to influence control.

Key details

Reporting holderSamsara BioCapital, L.P.
General partner of reporting holderSamsara BioCapital GP, LLC
Reporting holderSamsara Opportunity Fund, L.P.
General partner of reporting holderSamsara Opportunity Fund GP, LLC
IssuerEloxx Pharmaceuticals, Inc.
Managing member, samsara biocapital gp, llcSrinivas Akkaraju

How ELOX stock reacted

Close before

$19.07

Aug 13, 2026

First close after

-1.63%

$18.76

5 trading days

-5.40%

$18.04

Since filing

-34.45%

$12.50

✦ Ask GOAX AI about this filing — what it means for ELOX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ELOX?

Click here

Frequently asked questions

What did ELOX file with the SEC on Aug 14, 2026?

ELOX filed a SCHEDULE 13G (SEC filing). Samsara BioCapital, L.P. and affiliated entities filed a joint Schedule 13G reporting their beneficial ownership of Eloxx Pharmaceuticals common stock. The filing is a passive ownership disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did ELOX stock react to this filing?

ELOX closed at $19.07 before the filing and $18.76 on Aug 14, 2026 (-1.63%). Five trading days later: $18.04 (-5.40%).

Other ELOX SEC filings

Get alerts when ELOX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days